BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 27688158)

  • 1. Clinicopathological features and outcomes in patients with late recurrence of renal cell carcinoma after radical surgery.
    Kobayashi K; Saito T; Kitamura Y; Bilim V; Toba T; Kawasaki T; Hara N; Tanikawa T; Tomita Y
    Int J Urol; 2016 Feb; 23(2):132-7. PubMed ID: 27688158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological features of recurrence after radical surgery for nonmetastatic renal cell carcinoma.
    Ishimura T; Sakai I; Harada K; Hara I; Eto H; Miyake H
    Int J Clin Oncol; 2004 Oct; 9(5):369-72. PubMed ID: 15549586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
    Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
    Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological characteristics and prognosis of patients according to recurrence time after radical nephrectomy for localized renal cell carcinoma: a multicenter study of Anatolian Society of Medical Oncology (ASMO).
    Bozkurt O; Inanc M; Hacibekıroglu I; Esbah O; Seker M; Ulas A; Aydin K; Uysal M; Kücüköner M; Uncu D; Cıltas A; Unal OÜ; Durnali A; Demırcı U; Berk V; Tonyali O; Oksüzoglu B; Karaca H; Ozkan M
    Anticancer Res; 2014 Aug; 34(8):4463-70. PubMed ID: 25075086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microscopic venous invasion in renal cell carcinoma as a predictor of recurrence after radical surgery.
    Ishimura T; Sakai I; Hara I; Eto H; Miyake H
    Int J Urol; 2004 May; 11(5):264-8. PubMed ID: 15147540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different clinicopathological features between patients who developed early and late recurrence following surgery for renal cell carcinoma.
    Fujii Y; Ikeda M; Kurosawa K; Tabata M; Kamigaito T; Hosoda C; Okaneya T
    Int J Clin Oncol; 2015 Aug; 20(4):802-7. PubMed ID: 25445164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late recurrence of renal cell carcinoma >5 years after surgery: clinicopathological characteristics and prognosis.
    Park YH; Baik KD; Lee YJ; Ku JH; Kim HH; Kwak C
    BJU Int; 2012 Dec; 110(11 Pt B):E553-8. PubMed ID: 22578274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microscopic vascular invasion is the most relevant prognosticator after radical nephrectomy for clinically nonmetastatic renal cell carcinoma.
    Van Poppel H; Vandendriessche H; Boel K; Mertens V; Goethuys H; Haustermans K; Van Damme B; Baert L
    J Urol; 1997 Jul; 158(1):45-9. PubMed ID: 9186320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal cell carcinoma: evaluation of the 1997 TNM system and recommendations for follow-up after surgery.
    Gofrit ON; Shapiro A; Kovalski N; Landau EH; Shenfeld OZ; Pode D
    Eur Urol; 2001 Jun; 39(6):669-74; discussion 675. PubMed ID: 11464056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes and clinicopathologic variables associated with late recurrence after nephrectomy for localized renal cell carcinoma.
    Kim SP; Weight CJ; Leibovich BC; Thompson RH; Costello BA; Cheville JC; Lohse CM; Boorjian SA
    Urology; 2011 Nov; 78(5):1101-6. PubMed ID: 21903243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological T3a Upstaging of Clinical T1 Renal Cell Carcinoma: Outcomes According to Surgical Technique and Predictors of Upstaging.
    Jeong SH; Kim JK; Park J; Jeon HJ; Yoon MY; Jeong CW; Ku JH; Kim HH; Kwak C
    PLoS One; 2016; 11(11):e0166183. PubMed ID: 27861519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery.
    Lerner SE; Hawkins CA; Blute ML; Grabner A; Wollan PC; Eickholt JT; Zincke H
    J Urol; 1996 Jun; 155(6):1868-73. PubMed ID: 8618276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Presence of Vascular Mimicry Predicts High Risk of Clear Cell Renal Cell Carcinoma after Radical Nephrectomy.
    Zhou L; Chang Y; Xu L; Liu Z; Fu Q; Yang Y; Lin Z; Xu J
    J Urol; 2016 Aug; 196(2):335-42. PubMed ID: 26970566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological Stage T3a Significantly Increases Disease Recurrence across All Tumor Sizes in Renal Cell Carcinoma.
    Chevinsky M; Imnadze M; Sankin A; Winer A; Mano R; Jakubowski C; Mashni J; Sjoberg DD; Chen YB; Tickoo SK; Reuter VE; Hakimi AA; Russo P
    J Urol; 2015 Aug; 194(2):310-5. PubMed ID: 25676433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive surgical margin following radical nephrectomy is an independent predictor of local recurrence and disease-specific survival.
    Abu-Ghanem Y; Ramon J; Berger R; Kaver I; Fridman E; Leibowitz-Amit R; Dotan ZA
    World J Surg Oncol; 2017 Nov; 15(1):193. PubMed ID: 29096642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma.
    Blute ML; Itano NB; Cheville JC; Weaver AL; Lohse CM; Zincke H
    J Urol; 2003 Apr; 169(4):1276-81. PubMed ID: 12629342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk factors for recurrence in pT3aN0M0 renal cell carcinoma according to 2009 TNM classification].
    Utsunomiya N; Kono Y; Matsumoto K; Sumiyoshi T; Masuda N; Shiraishi Y; Negoro H; Tsunemori H; Sugino Y; Okubo K; Okada T; Segawa T; Muguruma K; Kawakita M
    Hinyokika Kiyo; 2014 Jan; 60(1):1-5. PubMed ID: 24594765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial nephrectomy versus radical nephrectomy for non-metastatic pathological T3a renal cell carcinoma: a multi-institutional comparative analysis.
    Oh JJ; Byun SS; Lee SE; Hong SK; Lee ES; Kim HH; Kwak C; Ku JH; Jeong CW; Kim YJ; Kang SH; Hong SH
    Int J Urol; 2014 Apr; 21(4):352-7. PubMed ID: 24118633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive factors for late recurrence in patients with stage T1 clear cell renal cell carcinoma: a multiinstitutional study.
    Ha YS; Park YH; Kang SH; Hong SH; Hwang TK; Byun SS; Kim YJ
    Clin Genitourin Cancer; 2013 Mar; 11(1):51-5. PubMed ID: 23017336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.